Gene · 9760
Papers2,030
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 2,030
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hyperprogression of cutaneous T cell lymphoma after anti-PD-1 treatment. | JCI Insight | 2023 | 36649072 | PubTator, text mining | PubMed |
| Reprogramming dysfunctional CD8+ T cells to promote properties associated with natural HIV control. | J Clin Invest | 2023 | 36647831 | PubTator, text mining | PubMed |
| Analysis of transcriptional changes in the immune system associated with pubertal development in a longitudinal cohort of children with asthma. | Nat Commun | 2023 | 36646693 | PubTator, text mining | PubMed |
| Single-cell RNA-seq integrated with multi-omics reveals SERPINE2 as a target for metastasis in advanced renal cell carcinoma. | Cell Death Dis | 2023 | 36646679 | PubTator, text mining | PubMed |
| Non-SMC condensin I complex subunit H participates in anti-programmed cell death-1 resistance of clear cell renal cell carcinomas. | Cell Prolif | 2023 | 36642844 | PubTator, text mining | PubMed |
| MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors. | Cancer Cell | 2023 | 36638785 | PubTator, text mining | PubMed |
On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates. | Breast Cancer Res | 2023 | 36635767 | PubTator, text mining | PubMed |
| Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma. | J Immunother Cancer | 2023 | 36631162 | PubTator, text mining | PubMed |
| Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities. | J Biomed Sci | 2023 | 36627707 | PubTator, text mining | PubMed |
| Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens. | Nat Genet | 2023 | 36624340 | PubTator, text mining | PubMed |
| A comprehensive single-cell map of T cell exhaustion-associated immune environments in human breast cancer. | Nat Commun | 2023 | 36609566 | PubTator, text mining | PubMed |
| STAT5A antagonizes TOX in CD8+ T cell exhaustion. | Nat Rev Immunol | 2023 | 36596846 | PubTator, text mining | PubMed |
| Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas. | Cancer Cell | 2023 | 36584673 | PubTator, text mining | PubMed |
| An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia. | Nat Cancer | 2023 | 36581735 | PubTator, text mining | PubMed |
| Seroepidemiology and Carriage of Diphtheria in Epidemic-Prone Area and Implications for Vaccination Policy, Vietnam. | Emerg Infect Dis | 2023 | 36573549 | PubTator, text mining | PubMed |
| Novel insights into Hodgkin lymphoma biology by single-cell analysis. | Blood | 2023 | 36548960 | PubTator, text mining | PubMed |
| Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity. | Nat Immunol | 2023 | 36543958 | PubTator, text mining | PubMed |
| Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries. | Nat Genet | 2023 | 36539618 | PubTator, text mining | PubMed |
| Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19. | Clin Immunol | 2023 | 36539107 | PubTator, text mining | PubMed |
| Hyperstabilization of T cell microvilli contacts by chimeric antigen receptors. | J Cell Biol | 2023 | 36520493 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9760/papers?page=33